Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Toronto Stock Exchange  >  Aurora Cannabis Inc    ACB   CA05156X1087

AURORA CANNABIS INC (ACB)
Mes dernières consult.
Most popular
Report
SummaryChartsNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Canada's Aurora Cannabis boosts stake in Australia-based Cann Group

share with twitter share with LinkedIn share with facebook
share via e-mail
0
12/04/2017 | 05:19pm CET

Canada's Aurora Cannabis Inc (>> Aurora Cannabis Inc) said on Monday it increased its stake in Australia-based Cann Group Ltd (>> Cann Group Ltd) to 22.9 percent from 19.9 percent, its latest move to expand in the cannabis industry.

Canada's Aurora Cannabis Inc (>> Aurora Cannabis Inc) said on Monday it increased its stake in Australia-based Cann Group Ltd (>> Cann Group Ltd) to 22.9 percent from 19.9 percent, its latest move to expand in the cannabis industry.

Aurora, already Cann Group's largest shareholder, said it bought the shares at A$2.50 ($1.90) apiece.

Shares of Cann Group ended 4.7 percent higher at A$3.14 on the Australian Stock Exchange on Monday.

Cann Group was the first Australian company to receive a license to research and cultivate cannabis for medical purposes.

Aurora will also invest C$12 million ($9.4 million) in Canadian biotechnology company Radient Technologies Inc <RTI.V>. The investment will increase Aurora's stake in Radient to 19.18 percent from 8.8 percent.

The investments come as Aurora - one of Canada's biggest cannabis makers - looks to expand ahead of expectations that Canada will legalize the production, sale and consumption of recreational marijuana.

Aurora is also trying to buy medical marijuana company CanniMed Therapeutics Inc (>> CanniMed Therapeutics Inc), which last week adopted a "poison pill" plan to prevent a takeover.

Radient's stock rose nearly 10 percent on Monday on the TSX Venture Exchange.

(Reporting by Yashaswini Swamynathan and Taenaz Shakir in Bengaluru; editing by Sai Sachin Ravikumar)

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on AURORA CANNABIS INC
01:02p AURORA CANNABIS : and its Subsidiary Pedanios GmbH Both Receive EU GMP Certifica..
12/05 Purified Cannabinoids Open New Opportunities in Pain Management
12/05 AURORA CANNABIS : Completes Larssen and H2 Biopharma Acquisitions
12/04 AURORA CANNABIS : Most actively traded companies on the TSX
12/04 Canada's Aurora Cannabis boosts stake in Australia-based Cann Group
12/04 AURORA CANNABIS : Increases Ownership Interest in Cann Group Ltd.
12/04 RADIENT TECHNOLOGIES : Aurora Cannabis Increases Ownership Interest in Radient T..
12/01 AURORA CANNABIS : Most actively traded companies on the TSX
12/01 RADIENT TECHNOLOGIES : Appoints Terry Booth to Board of Directors
12/01 AURORA CANNABIS : Responds to CanniMed's Adoption of Poison Pill Tactic
More news
News from SeekingAlpha
12/10 Aurora Cannabis Is Growing Like A Weed, But Are They A Good Investment?
12/05 Marijuana Stocks Ready To Turn A New Leaf In 2018
11/30 MARIJUANA STOCKS : Buy Canadian Big- And Mid-Caps; Tax Loss Selling Focused Wait..
11/29 Cannimed adopts shareholder rights plan as it considers Aurora bid
11/27 How To Make Money On Cannabis Stocks In The Next Three Months
Financials ( CAD)
Sales 2018 73,5 M
EBIT 2018 3,04 M
Net income 2018 19,9 M
Finance 2018 17,9 M
Yield 2018 -
P/E ratio 2018 177,25
P/E ratio 2019 39,39
EV / Sales 2018 38,7x
EV / Sales 2019 10,6x
Capitalization 2 862 M
Chart AURORA CANNABIS INC
Duration : Period :
Aurora Cannabis Inc Technical Analysis Chart | ACB | CA05156X1087 | 4-Traders
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 4
Average target price 5,61  CAD
Spread / Average Target -21%
Managers
NameTitle
Terry Booth Chief Executive Officer & Non-Independent Director
Steve Dobler President & Director
Michael Singer Chairman
Allan Cleiren Chief Operating Officer
Glen W. Ibbott Chief Financial Officer
Sector and Competitors